Skip to content

Effect of Remote Ischemic Preconditioning in treatment of burns

Effect of Remote Ischemic Preconditioning on complications and clinical outcome in patients with severe burn, A randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210524051384N5
Enrollment
32
Registered
2021-11-09
Start date
2021-12-06
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. Burn and corrosion of head, face, and neck

Interventions

Intervention 1: Intervention group (Patients receiving RIPC procedure): RIPC procedure will be performed on the first day of hospitalization under the following protocol twice with an interval of 12 h

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 65 years Acute burn injury within 24 hours 20 to 50 percent TBSA (total body surface area) Patient classified as class 1 ASA (American Society of Anesthesiologists) : Normal healthy person Signed informed consent

Exclusion criteria

Exclusion criteria: Severe hypertension = BP (Blood pressure) =160/90 mmHg Ischemic changes in ECG (Electrocardiogram) Pregnant women Peripheral vascular diseases Inhalation injury Burn shock: decreased CO (Cardiac output), increased systemic vascular resistance, hypovolemia and hypoperfusion induced by severe burn injury Patients with burn injury in both upper limbs in which the procedure couldn't be performed

Design outcomes

Primary

MeasureTime frame
Graft to TBSA (total body surface area) percent ratio. Timepoint: At the admission. Method of measurement: Measurements based on Wallace criteria.;Total fluid requirement. Timepoint: At discharge. Method of measurement: Based on patients' files.;Hospital stay. Timepoint: At discharge. Method of measurement: Based on patients' files.;Final clinical outcome. Timepoint: At discharge. Method of measurement: Based on patients' files.

Secondary

MeasureTime frame
Infection. Timepoint: Day 1, 3, 7, 14 and 28 post admission. Method of measurement: Based on examination done by evaluators.;Itching. Timepoint: Day 1, 3, 7, 14 and 28 post admission. Method of measurement: Asking patients.;Burning. Timepoint: Day 1, 3, 7, 14 and 28 post admission. Method of measurement: Asking patients.;Shock index. Timepoint: Hour 1, 6, 12, 24 post admission. Method of measurement: Heartbeat per minute / systolic Blood pressure in mmHg.;SIRS (Systemic inflammatory response syndrome). Timepoint: Day 1, 3, 7, 14 and 28 ?post admission. Method of measurement: Based on body temperature, heart rate, respiratory rate, and WBC (white blood cells) count.;Cr (creatinine). Timepoint: Day 1, 3, 7, 14 and 28 ?post admission. Method of measurement: Based on patients' laboratory results.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Mobayen

Rasht University of Medical Sciences

Maziar.mobayen@gmail.com+98 13 3336 8540

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026